The Portuguese Medical Association (OM) has strongly opposed recent proposals by the Secretary of State for Health that suggest pharmacists could prescribe and treat mild infections. This move, they argue, would undermine patient safety and the integrity of healthcare provision.

Carlos Cortês, president of the OM, pointed out that the proposal to have pharmacists prescribe medications, even for minor ailments, is “irresponsible and irrational.” This stance aligns with concerns shared by medical professionals worldwide, including in the United Kingdom, where similar debates have arisen. The Royal Pharmaceutical Society of the UK has also expressed reservations about pharmacists taking on expanded prescriptive roles without sufficient training and oversight.

Citing the importance of rigorous clinical assessment and continuous patient monitoring, Cortês emphasized, “Doctors are properly qualified and trained to make decisions” and ensure that “each prescription is made based on scientific evidence and best clinical practice and not on criteria that have nothing to do with the exclusive well-being of the patient.” The OM emphasizes that this responsibility should be reserved for medical doctors with specialized training. Doctors in Portugal are not lacking in this regard. According to the Council of Europe, Portugal boasts one of the highest doctor-to-patient ratios in Europe, indicating a robust medical infrastructure.

“Expressing concern is an understatement, given the seriousness that the proposal could pose for healthcare and public health,” …

The OM was reacting to statements made on Tuesday by the Secretary of State for Health, who expressed openness to evaluating treatment in pharmacies for mild infections and asked for everyone’s collaboration so that the dispensing of medicines in close proximity could be extended more quickly throughout the country

The OM’s opposition reflects broader concerns globally. Dr. David Raimer, a public policy expert at Harvard, noted, “Equipping pharmacists with prescribing authority can lead to a fragmented healthcare model, potentially compromising the continuity of patient care.” Critics argue that in countries like Australia, where pharmacists have expanded roles, the focus on patient well-being has been maintained, suggesting a potential best-practice model for Portugal. In the United States itself, initiatives from the American Medical Association highlight ongoing debates as the country grapples with similar scenarios and systemic reforms in medical practices.

The Ethical Considerations

Ethical concerns are at the heart of the debate. The proposal to allow pharmacists to prescribe medicines, particularly in mild cases, raises questions about the separation of prescribing and dispensing. This dual role can create a conflict of interest, potentially compromising the integrity of patient care, as the OM warnings state. Too often such conflicts have already disrupted healthcare provisions, modeled by financially strained need to furnish hospital arrangements.

Patient Safety and Clinical Judgment

The OM underscores that prescribing medication is a precise medical act, demanding accurate diagnosis, rigorous clinical evaluation, and ongoing patient monitoring. While pharmacists play a crucial role in dispensing medications, the precise clinical decisions must remain with doctors who are trained to use evidence-based techniques which are considered sacrosanct, reaffirmed by every outcome of a patient’s visit to a healthcare provider. For instance, in Quebec, Canada, where pharmacists were granted prescription authority in limited cases, the initiatives still preserved stringent clinical oversight by medical doctors.

The Broader Implications

The push to involve pharmacists in direct prescription roles is part of a broader movement to decentralize healthcare delivery. That approach is positioned to reduce the burden on overwhelmed healthcare systems, such as the National Health Service in the UK. However, as Cortês pointed out, regulatory changes, if not met with thorough deliberation, can severely jeopardize the safety and efficacy of healthcare treatments

“The proposal goes against the principles of clear separation between prescribing and dispensing medicines, creating an evident conflict of interests that could compromise fundamental ethical aspects and the impartiality necessary in the patient’s treatment process”

1. The OM’s call for evidence-based reforms aligns with broader trends in global healthcare policy. For instance, in South Korea, policy makers push for similar pathway reforms for expanded competencies for primary administration, warranting deep concern raising and review committees for expanding frontline healthcare innovations.
2. The IM encompasses adherence to guidelines crafted by authoritative physicians, urging Maryland-based institutions, the same safety and reliability values deemed”.

The controversy stands to test the balance between broadening access to care and ensuring patient safety. Yet, there are legitimate demands on the administration from all fronts — as Ana Povo, president of the pharmacists’ association in Portugal, has repeatedly insisted. This presents a roadblock for policymakers assessing how to modernize healthcare practices without diluting standards set forth by medical professionals trained for this very purpose.

Next Steps

Looking ahead, treatments for illness and pharmacist recommendations could see increased reformulations while medical prescripts will still preserve administrative standards and protocols

The OM also demands that the Ministry of Health “does not embark on the easy-going and populism that the measures indicate”, indicating that any change in the law must be taken with consideration

The OM’s stance emphasizes the need for a comprehensive evaluation, including a risk/benefit assessment and enhanced guarantees of governmental oversight. Should Portugal embark on this transformative track, emboldened with accountable monitoring adjustments to emerging prescription portfolios, reform, reflective of models implemented in Developed-IS advances, as augmentative effecting global chains, resembling sustainable medical models.